Pulmonary surfactant is a complex and highly surface active material composed of lipids and
proteins which is found in the fluid lining the alveolar surface of the lungs. Surfactant …

Congenital diaphragmatic hernia affects over 1000 babies born in the United States each
year. 4% to 10% of infant deaths from all congenital anomalies are caused by diaphragmatic …

Purpose: The aim of this study was to review all available studies reported in the English-
language literature from 1975 through 1998, and by meta-analysis assess the importance of …

Abstract Congenital Diaphragmatic Hernia (CDH) is defined by the presence of an orifice in
the diaphragm, more often left and posterolateral that permits the herniation of abdominal …

Purpose: The optimal therapy for congenital diaphragmatic hernia (CDH) is evolving. This
study analyzes the results of treatment of CDH in a large tertiary care pediatric center using …

Congenital diaphragmatic hernia (CDH) occurs in 1 of every 2,000 to 4,000 births and
accounts for 8% of all major congenital anomalies. Recurrence risk for a subsequent …

OBJECTIVES: To determine the impact of surfactant replacement on survival, need for
extracorporeal membrane oxygenation (ECMO), and chronic lung disease in term infants …

PURPOSE: To understand the natural history of right congenital diaphragmatic hernia
(CDH), the authors retrospectively reviewed 27 cases of right CDH that presented for …

To determine the role of inhaled nitric oxide (NO) in a population of critically ill hypoxic near-
term infants and to determine the dose response to inhaled NO, we examined a consecutive …

Surfactant replacement therapy (SRT) has a proven role in the treatment of neonatal
respiratory distress syndrome and severe meconium aspiration syndrome in infants, and …